SCHEMBL5378926

SCHEMBL5378926

Cc1ccc(OB(OCc2ccccn2)Oc2ccc(C)c(Cl)c2)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
SYK P43405 6/20 0.41
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPK14 Q16539 1/20 0.38
SMO Q99835 1/20 0.38
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAOA P21397 1/20 0.37
AURKB Q96GD4 1/20 0.37
INCENP Q9NQS7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12270805 0.79 KDM4E (0.46) KDM4ESYKHTR2CHTR2BSMN1; SMN2
SCHEMBL2407527 0.79 KDM4E (0.44) KDM4ESYKDRD2DRD4DRD3
SCHEMBL5376702 0.77 SMN1; SMN2 (0.44) KDM4ESYKDRD2ALDH1A1SMN1; SMN2
SCHEMBL12319351 0.75 KDM4E (0.43) KDM4ESYKHTR2CHTR2BNPC1
SCHEMBL5368632 0.73 DRD2 (0.36) KDM4EDRD2DRD4DRD3ALDH1A1
SCHEMBL5377182 0.73 LMNA (0.38) KDM4EDRD2DRD4DRD3SMN1; SMN2
SCHEMBL6659169 0.73 LMNA (0.42) KDM4EDRD2DRD4DRD3ALDH1A1
SCHEMBL12270722 0.72 SYK (0.40) KDM4ESYKHTR2CHTR2BSMN1; SMN2
SCHEMBL1555855 0.71 DRD2 (0.40) KDM4EDRD2DRD4DRD3ALDH1A1
SCHEMBL28049606 0.70 SYK (0.57) KDM4ESYKHTR2CALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 US claimed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 EP claimed
US-7217701-B2 Intracellular calcium concentration increase inhibitors KATSUHIKO MIKOSHIBA (JP) 2007-05-15 US disclosed
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors MIKOSHIBA, KATSUHIKO (JP) 2004-12-23 US disclosed
EP-1444981-A1 INTRACELLULAR CALCIUM CONCENTRATION INCREASE INHIBITORS Mikoshiba, Katsuhiko (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259842-A1 Intracellular calcuim concentration increase inhibitors CAB39, BPGM, ORAI1 KDM4E 4858/4885SYK 315/4885DRD2 4282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.